Evidence mapPaperPMID 39323839Full record

ArticleHeliyon2024

Identification and characterization of

Xiao-Lei Ji, Yi-Nuo Xiao, Rui-Min Sun, Zhi-Wen Tan, Ya-Qi Zhu, Xue-Ling Li, Lan-Fang Li, Shao-Yang Hou

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Functional Characterization ofInternational journal of molecular sciences · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiao-Lei JiXinjiang Agricultural Vocational and Technical College, Changji, 831100, PR China.
Yi-Nuo XiaoJining Medical University, Jining, 272000, PR China.
Rui-Min SunCollege of Pharmacy, Heze University, Heze, 274015, PR China.
Zhi-Wen TanCollege of Pharmacy, Heze University, Heze, 274015, PR China.
Ya-Qi ZhuCollege of Pharmacy, Heze University, Heze, 274015, PR China.
Xue-Ling LiCollege of Pharmacy, Heze University, Heze, 274015, PR China.
Lan-Fang LiCollege of Pharmacy, Heze University, Heze, 274015, PR China.
Shao-Yang HouCollege of Pharmacy, Heze University, Heze, 274015, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Baicalein, showing higher bioavailability and stronger pharmacological activity, can be obtained via a β-glucuronidase (GUS)-catalyzed transformation of baicalein 7-O-β-D-glucuronide (baicalin). Recently, we have found that the fermentation broth of

Indexed as

BaicalinBiotransformationLacticaseibacillus rhamnosusβ-Glucuronidase

Identifiers

PMID39323839
PMCPMC11422588

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.